Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10333918rdf:typepubmed:Citationlld:pubmed
pubmed-article:10333918lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10333918lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10333918lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:10333918lifeskim:mentionsumls-concept:C0271650lld:lifeskim
pubmed-article:10333918lifeskim:mentionsumls-concept:C0013878lld:lifeskim
pubmed-article:10333918lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:10333918pubmed:issue1lld:pubmed
pubmed-article:10333918pubmed:dateCreated1999-7-13lld:pubmed
pubmed-article:10333918pubmed:abstractTextImpaired glucose tolerance (IGT) in association with insulin resistance is considered to be a risk factor for atherosclerosis. Thus, patients with IGT may have abnormal lipid and lipoprotein profiles. The purpose of this study was to investigate presence of remnant-type hyperlipoproteinemia in patients with IGT.lld:pubmed
pubmed-article:10333918pubmed:languageenglld:pubmed
pubmed-article:10333918pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:citationSubsetIMlld:pubmed
pubmed-article:10333918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333918pubmed:statusMEDLINElld:pubmed
pubmed-article:10333918pubmed:monthJanlld:pubmed
pubmed-article:10333918pubmed:issn0149-5992lld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:KitagawaYYlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:IshikawaYYlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:YamadaSSlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:WatanabeNNlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:TaniguchiTTlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:KurimotoYYlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:YonedaNNlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:NamuraHHlld:pubmed
pubmed-article:10333918pubmed:authorpubmed-author:TaketohHHlld:pubmed
pubmed-article:10333918pubmed:issnTypePrintlld:pubmed
pubmed-article:10333918pubmed:volume22lld:pubmed
pubmed-article:10333918pubmed:ownerNLMlld:pubmed
pubmed-article:10333918pubmed:authorsCompleteYlld:pubmed
pubmed-article:10333918pubmed:pagination152-6lld:pubmed
pubmed-article:10333918pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:meshHeadingpubmed-meshheading:10333918...lld:pubmed
pubmed-article:10333918pubmed:year1999lld:pubmed
pubmed-article:10333918pubmed:articleTitleElevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.lld:pubmed
pubmed-article:10333918pubmed:affiliationHealth Care and Promotion Center, Yodogawa Christian Hospital, Osaka, Japan.lld:pubmed
pubmed-article:10333918pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10333918pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10333918lld:pubmed